Nobuhiro Watanabe

Summary

Affiliation: National Hospital Organization
Country: Japan

Publications

  1. doi Outcome of bone marrow transplantation from HLA-identical sibling donor in children with hematological malignancies using methotrexate alone as prophylaxis for graft-versus-host disease
    Nobuhiro Watanabe
    Division of Hematology and Oncology, Children s Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
    Int J Hematol 88:575-82. 2008
  2. doi Relationship between tacrolimus blood concentrations and clinical outcome during the first 4 weeks after SCT in children
    N Watanabe
    Division of Hematology and Oncology, Children s Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
    Bone Marrow Transplant 45:1161-6. 2010
  3. doi Total body irradiation and melphalan as a conditioning regimen for children with hematological malignancies undergoing transplantation with stem cells from HLA-identical related donors
    Nobuhiro Watanabe
    Children s Medical Center, Japanese Red Cross, Nagoya, Japan
    Pediatr Transplant 15:642-9. 2011
  4. doi Incidence, clinical features, and risk factors of idiopathic pneumonia syndrome following hematopoietic stem cell transplantation in children
    Hirotoshi Sakaguchi
    Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
    Pediatr Blood Cancer 58:780-4. 2012
  5. doi Prognostic factors for outcomes of pediatric patients with refractory or relapsed acute leukemia undergoing allogeneic progenitor cell transplantation
    Nobuhiro Watanabe
    Division of Hematology and Oncology, Children s Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
    Biol Blood Marrow Transplant 17:516-23. 2011
  6. doi Excellent outcome of allogeneic bone marrow transplantation for Fanconi anemia using fludarabine-based reduced-intensity conditioning regimen
    Akira Shimada
    Department of Pediatrics, Nagoya University Graduate School of Medicine, 65 Tsurumai Cho, Showa Ku, Nagoya, Aichi 466 8550, Japan
    Int J Hematol 95:675-9. 2012
  7. doi Danaparoid as the prophylaxis for hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation in childhood hematological malignancy
    Hirotoshi Sakaguchi
    Division of Haematology and Oncology, Children s Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
    Pediatr Blood Cancer 55:1118-25. 2010
  8. doi Molecular lesions in childhood and adult acute megakaryoblastic leukaemia
    Asahito Hama
    Department of Paediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
    Br J Haematol 156:316-25. 2012
  9. doi Risk factors for early death in neonates with Down syndrome and transient leukaemia
    Hideki Muramatsu
    Department of Paediatrics, Nagoya University Graduate School of Medicine, Japanese Red Cross Nagoya First Hospital, Aichi, Japan
    Br J Haematol 142:610-5. 2008
  10. doi Invasive fungal infections in pediatric patients with hematologic malignancies receiving oral amphotericin B solution and early intravenous administration of fluconazole
    Nobuhiro Watanabe
    Division of Hematology and Oncology, Children s Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
    J Pediatr Hematol Oncol 33:270-5. 2011

Collaborators

Detail Information

Publications13

  1. doi Outcome of bone marrow transplantation from HLA-identical sibling donor in children with hematological malignancies using methotrexate alone as prophylaxis for graft-versus-host disease
    Nobuhiro Watanabe
    Division of Hematology and Oncology, Children s Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
    Int J Hematol 88:575-82. 2008
    ..1 and 39.5%, respectively. These results suggest that GVHD prophylaxis with MTX alone is safe and effective in young children under 10 years old at transplantation and in a setting other than female donor to male recipient...
  2. doi Relationship between tacrolimus blood concentrations and clinical outcome during the first 4 weeks after SCT in children
    N Watanabe
    Division of Hematology and Oncology, Children s Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
    Bone Marrow Transplant 45:1161-6. 2010
    ..Multivariate analysis showed that tacrolimus concentration was significantly associated with clinical outcomes. Mean whole-blood level of tacrolimus as continuous infusion should be maintained at > or =7 ng/ml for pediatric patients...
  3. doi Total body irradiation and melphalan as a conditioning regimen for children with hematological malignancies undergoing transplantation with stem cells from HLA-identical related donors
    Nobuhiro Watanabe
    Children s Medical Center, Japanese Red Cross, Nagoya, Japan
    Pediatr Transplant 15:642-9. 2011
    ..2%, 88.1%, and 23.1%, respectively (pā€ƒ<ā€ƒ0.05). MEL/TBI for pediatric patients with hematological malignancies was associated with lower relapse rates and no increase in toxicity, resulting in better survival...
  4. doi Incidence, clinical features, and risk factors of idiopathic pneumonia syndrome following hematopoietic stem cell transplantation in children
    Hirotoshi Sakaguchi
    Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
    Pediatr Blood Cancer 58:780-4. 2012
    ..Idiopathic pneumonia syndrome (IPS) is a severe complication that can occur after hematopoietic stem cell transplantation (HSCT) and is often associated with a fatal outcome despite intensive supportive care...
  5. doi Prognostic factors for outcomes of pediatric patients with refractory or relapsed acute leukemia undergoing allogeneic progenitor cell transplantation
    Nobuhiro Watanabe
    Division of Hematology and Oncology, Children s Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
    Biol Blood Marrow Transplant 17:516-23. 2011
    ....
  6. doi Excellent outcome of allogeneic bone marrow transplantation for Fanconi anemia using fludarabine-based reduced-intensity conditioning regimen
    Akira Shimada
    Department of Pediatrics, Nagoya University Graduate School of Medicine, 65 Tsurumai Cho, Showa Ku, Nagoya, Aichi 466 8550, Japan
    Int J Hematol 95:675-9. 2012
    ..BMT using FLU/low-dose CY/ATG -based regimens regardless to the donor is a beneficial therapeutic approach for FA patients...
  7. doi Danaparoid as the prophylaxis for hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation in childhood hematological malignancy
    Hirotoshi Sakaguchi
    Division of Haematology and Oncology, Children s Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
    Pediatr Blood Cancer 55:1118-25. 2010
    ..Therapeutic modalities for established VOD are limited, and severe VOD characterized by multiple organ failure is associated with a fatal prognosis despite intensive supportive care...
  8. doi Molecular lesions in childhood and adult acute megakaryoblastic leukaemia
    Asahito Hama
    Department of Paediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
    Br J Haematol 156:316-25. 2012
    ..ASXL1, IDH1/2, DNMT3A, RUNX1 and CBL mutations were not found in any of the patient group studied, while NRAS mutation was identified in two patients with paediatric non-DS-AMKL...
  9. doi Risk factors for early death in neonates with Down syndrome and transient leukaemia
    Hideki Muramatsu
    Department of Paediatrics, Nagoya University Graduate School of Medicine, Japanese Red Cross Nagoya First Hospital, Aichi, Japan
    Br J Haematol 142:610-5. 2008
    ..5% (6/11) died early]. This stratification system may be useful for identifying high-risk patients who need early therapeutic interventions...
  10. doi Invasive fungal infections in pediatric patients with hematologic malignancies receiving oral amphotericin B solution and early intravenous administration of fluconazole
    Nobuhiro Watanabe
    Division of Hematology and Oncology, Children s Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
    J Pediatr Hematol Oncol 33:270-5. 2011
    ..Our results indicate that amphotericin B oral solution and early intravenous fluconazole may be effective in reducing the incidence and mortality of IFI in pediatric patients with hematologic malignancies...
  11. doi Comparison of Donor Sources in Hematopoietic Stem Cell Transplantation for Childhood Acute Leukemia: A Nationwide Retrospective Study
    Hirotoshi Sakaguchi
    Department of Hematology and Oncology, Children s Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan Electronic address
    Biol Blood Marrow Transplant 22:2226-2234. 2016
    ..20; Pā€‰=ā€‰.03, compared to ID-BMT) in the myeloablative setting for childhood high-risk acute leukemia...
  12. ncbi Wiskott-Aldrich syndrome is an important differential diagnosis in male infants with juvenile myelomonocytic leukemialike features
    Nobuhiro Watanabe
    Division of Hematology and Oncology, Children s Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan nagoyta 1st jrc or jp
    J Pediatr Hematol Oncol 29:836-8. 2007
    ..After stem cell transplantation, he is alive in good condition with normal WASP expression. WAS should be considered as a differential diagnosis in male infants with juvenile myelomonocytic leukemialike features...
  13. doi Acute megakaryoblastic leukaemia (AMKL) in children: a comparison of AMKL with and without Down syndrome
    Asahito Hama
    Department of Paediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
    Br J Haematol 140:552-61. 2008
    ..81) with a median follow-up of 78 months (range, 20-243 months). Our study shows the diverse heterogeneity of childhood AMKL and the need for subclassification according to cytogenetic and morphological features...